Clinical trial
Effects on Quality of Life Following Dysport Treatment in Post-stroke Spasticity…
NCT00216411 · Ipsen, Industry · Completed
Key facts
| NCT number | NCT00216411 |
|---|---|
| Title | Effects on Quality of Life Following Dysport Treatment in Post-stroke Spasticity of the Arm |
| Official title | A Prospective Phase IV, Multicentre, Placebo-controlled Study to Demonstrate Changes in the Quality of Life Following DYSPORT Intramuscular Injection in the Treatment of Upper Limb Spasticity in Adult Post-Stroke Patients |
| Lead sponsor | Ipsen, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Cerebrovascular Accident, Muscle Spasticity |
| Intervention type | Biological, Drug |
| Interventions | Botulinum toxin type A, Placebo |
| Enrollment | 96 |
| Start date | Nov 1, 2004 |
| Primary completion | Jul 20, 2006 |
| Completion | Jul 20, 2006 |
| First posted | Sep 22, 2005 |
| Last update posted | Jul 29, 2019 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: